Collapsing glomerulopathy in collagen vascular-like disease

Lupus

Volumn 23, Issue 1, 2014, Pages 75-80

  Nasr, R ^a   Johns, C ^b   Gertner, E ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b REGIONS HOSPITAL   (United States)

Author keywords

antinuclear antibody; collagen vascular disease; Collapsing glomerulopathy; podocytopathy

Indexed keywords

ANTINUCLEAR ANTIBODY; CYCLOSPORIN; HYDROXYCHLOROQUINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; COLLAGEN DISEASE; COLLAPSING GLOMERULOPATHY; FEMALE; FOLLOW UP; GLOMERULOPATHY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; PROTEINURIA; SEROLOGY; VASCULAR DISEASE;

ANTINUCLEAR ANTIBODY; COLLAGEN VASCULAR DISEASE; COLLAPSING GLOMERULOPATHY; PODOCYTOPATHY;

ADULT; COLLAGEN DISEASES; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED;

EID: 84890502512     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313513509     Document Type: Article

References (15)

1. Weiss MA, Daquioag E, Margolin EG, Pollak VE. Nephrotic syndrome, progressive irreversible renal failure, and glomerular "collapse": A new clinicopathologic entity?. Am J Kidney Dis. 1986 ; 7: 20-28
2. Detwiler RK, Falk RJ, Hogan SL, Jennette JC. Collapsing glomerulopathy: A clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int. 1994 ; 45: 1416-1424
3. Laurinavicius A, Hurwitz S, Rennke HG. Collapsing glomerulopathy in HIV and non-HIV patients: A clinicopathological and follow-up study. Kidney Int. 1999 ; 56: 2203-2213
4. Salvatore SP, Barisoni LM, Herzenberg AM, Chander PN, Nickeleit V, Seshan SV. Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease. Clin J Am Soc Nephrol. 2012 ; 7: 914-925
5. Valeri A, Barisoni L, Appel GB, Seigle R, D'Agati V. Idiopathic collapsing focal segmental glomerulosclerosis: A clinicopathologic study. Kidney Int. 1996 ; 50: 1734-1746
6. Rifkin SI, Gutta H, Nair R, McFarren C, Wheeler DE. Collapsing glomerulopathy in a patient with mixed connective tissue disease. Clin Nephrol. 2011 ; 75: 32-36
7. Bennett AN, Peterson P, Sangle S, et al. Adult onset Still's disease and collapsing glomerulopathy: Successful treatment with intravenous immunoglobulins and mycophenolate mofetil. Rheumatology (Oxford). 2004 ; 43: 795-799
8. Haas M. Collapsing glomerulopathy in systemic lupus erythematosus: An extreme form of lupus podocytopathy?. Clin J Am Soc Nephrol. 2012 ; 7: 878-880
9. Kraft SW, Schwartz MM, Korbet SM, Lewis EJ. Glomerular podocytopathy in patients with systemic lupus erythematosus. J Am Soc Nephrol. 2005 ; 16: 175-179
10. Avila-Casado Mdel C, Perez-Torres I, Auron A, Soto V, Fortoul TI, Herrera-Acosta J. Proteinuria in rats induced by serum from patients with collapsing glomerulopathy. Kidney Int. 2004 ; 66: 133-143
11. Matsusaka T, Xin J, Niwa S, et al. Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury. J Am Soc Nephrol. 2005 ; 16: 1013-1023
12. El Karoui K, Hill GS, Karras A, et al. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies. Kidney Int. 2011 ; 79: 643-654
13. Kopp JB, Smith MW, Nelson GW, et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet. 2008 ; 40: 1175-1184
14. Genovese G, Tonna SJ, Knob AU, et al. A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9. Kidney Int. 2010 ; 78: 698-704
15. Kofman T, Narjoz C, Raimbourg Q, et al. Collapsing glomerulopathy associated lupus in a black female with homozygous APOL1 mutation. Lupus. 2012 ; 21: 1459-1462